Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

被引：0
|
作者：
Ghadeer K. Dawwas
Geoffrey D. Barnes
机构：
[1] University of Pennsylvania,Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine
[2] University of Pennsylvania,Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine
[3] Leonard Davis Institute of Health Economics,Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center
[4] University of Pennsylvania,undefined
[5] University of Michigan Health System,undefined
[6] University of Michigan,undefined
[7] North Campus Research Complex,undefined
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
Anticoagulants; DOACs; Warfarin; Atrial fibrillation; Valvular heart disease; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：731 / 738
页数：7
相关论文
共 50 条
  • [11] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
    Renda, Giulia
    Ricci, Fabrizio
    Giugliano, Robert P.
    De Caterina, Raffaele
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1363 - 1371
  • [12] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Moon, Inki
    Lee, So-Ryoung
    Choi, Eue-Keun
    Lee, Euijae
    Jung, Jin-Hyung
    Han, Kyung-Do
    Cha, Myung-Jin
    Oh, Seil
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [13] Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation
    Shah, Siddharth
    Garg, Jalaj
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (10) : 1489 - 1490
  • [14] Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation
    Masotti, Luca
    Di Napoli, Mario
    Ageno, Walter
    Imberti, Davide
    Becattini, Cecilia
    Paciaroni, Maurizio
    Godoy, Daniel Augustin
    Cappelli, Roberto
    Landini, Giancarlo
    Panigada, Grazia
    Iori, Ido
    Prisco, Domenico
    Agnelli, Giancarlo
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 8 - 21
  • [15] Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation
    Wang, Yu-Ting
    Chen, Jo-Hsin
    Liao, Shu-Fen
    Chen, Yu-Jen
    Lip, Gregory Y. H.
    Yeh, Jong-Shiuan
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
  • [16] The Use of Direct Oral Anticoagulants for Valvular Atrial Fibrillation in Central Australia
    Sawant, Sonia
    Freedman, Gabrielle
    Terrett, Sally
    Garcia, Ana
    Khandkar, Chinmay
    Sivashanmugarajah, Anosh
    Baumann, Angus
    CIRCULATION, 2024, 150
  • [17] Utilization of Oral Anticoagulants in Patients with Non Valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Delay, Marc
    Maury, Philippe
    Rollin, Anne
    Calmels, Violaine
    Pathak, Atul
    Bura-Riviere, Alessandra
    Montastruc, Jean-Louis
    Bagheri, Haleh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 77 - 78
  • [18] Utilization of oral anticoagulants in patients with non valvular atrial fibrillation
    Saliba, L.
    Mondoly, P.
    Duparc, A.
    Delay, M.
    Maury, P.
    Rollin, A.
    Calmels, V.
    Pathak, A.
    Bura-Riviere, A.
    Montastruc, J. L.
    Bagheri, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 111 - 111
  • [19] Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Ozbek, Kerem
    Cicekcioglu, Huelya
    Cetin, Mustafa
    Duyuler, Pinar Turker
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 266 - 266
  • [20] Comparative Outcomes of Direct Oral Anticoagulants versus Warfarin in Morbidly Obese Patients With Non-valvular Atrial Fibrillation
    Barakat, Amr F.
    Jain, Sandeep
    Masri, Ahmad
    Senussi, Mourad
    Wang, Yisi
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh R.
    CIRCULATION, 2019, 140
12345